A high number of patients who present to the hospital emergency room (ER) with suspected heart problems fall through the catchment for acute coronary syndrome because it is not immediately detected with current tests. ER physicians require a rapid and accurate method to determine which patients require immediate life saving medical treatment.
The ED team will take a small blood sample from the patient. This will then be analysed using standard hospital laboratory equipment and the reagents supplied by Upstream Medical Technologies. The results will quickly and accurately inform the emergency physician and cardiologist as to the best treatment for the patient.
Biomarker based testing
Based on many years of research, the first of our new class of biomarker-based diagnostic tests can detect imminent heart attack BEFORE tissue damage occurs, increasing survival rates and leading to improved patient recovery.
Incorporated in 2015, Upstream Medical Technologies aims to create sustainable value via a diagnostics platform that uses patented technology based on specialist protein peptides (so called signal peptides) from an internationally renowned research group. Our pipeline of tests enable earlier diagnosis for improved patient recovery.